NEW YORK (GenomeWeb News) – The UK's Medical Research Council plans to invest more than £150 million ($241 million) to beef up its national clinical research chops in key areas by funding the acquisition and development of new technologies, MRC said yesterday.

The technologies being targeted by the funding are to be aimed at advancing methods of genomic research and studying diseases in humans, as well as for stratifying diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.